Extract
R v The Licensing Authority and Another
No longer available (Autolink)
See the full content of this document
Core Citations
CONSIDERS
CONSIDERS
This document cites
-
R v Monopolies and Mergers Commission and Another ex parte South Yorkshire Transport Ltd and Others
-
R v Licensing Authority Established under Medicines Act 1968, ex parte Smith Kline & French Laboratories Ltd
-
Edwards (Inspector of Taxes) v Bairstow
-
Bolton Metropolitan District Council v Secretary of State for the Environment (Practice Note)
-
R v Medicines Control Agency, ex parte Pharma Nord Ltd
See all quotations
-
Medicines Act 1968
-
The Queen v The Licensing Authority established by the Medicines Act 1968 (acting by The Medicines Control Agency), ex parte Generics (UK) Ltd, The Wellcome Foundation Ltd and Glaxo Operations UK Ltd and Others.
-
Upjohn Ltd v The Licensing Authority established by the Medicines Act 1968 and Others.
-
The Queen contra Licensing Authority of the Department of Health y Norgine Ltd, ex parte Scotia Pharmaceuticals Ltd.
-
The Queen contra The Medicines Control Agency, ex parte Smith & Nephew Pharmaceuticals Ltd y Primecrown Ltd contra The Medicine Control Agency.
-
Council Directive 75/318/EEC of 20 May 1975 on the approximation of the laws of Member States relating to analytical, pharmaco-toxicological and clinical standards and protocols in respect of the testing of proprietary medicinal products
-
Council Directive 65/65/EEC of 26 January 1965 on the approximation of provisions laid down by Law, Regulation or Administrative Action relating to proprietary medicinal products
-
Commission Directive 91/507/EEC of 19 July 1991 modifying the Annex to Council Directive 75/318/EEC on the approximation of the laws of Member States relating to analytical, pharmacotoxicological and clinical standards and protocols in respect of the testing of medicinal products
-
Council Directive 87/21/EEC of 22 December 1986 amending Directive 65/65/EEC on the approximation of provisions laid down by law, regulation or administrative action relating to proprietary medicinal products